Lourdes Mendez, MD, PhD

Dr. Lourdes Mendez received her medical degree from Albert Einstein College of Medicine, as well as a PhD in Cell Biology. She completed her residency at Weill Cornell-New York Presbyterian and while a fellow in hematology/oncology at BIDMC, undertook a post-doctoral fellowship in cancer genetics. Most recently, Dr. Mendez was an Instructor of Medicine at Harvard Medical School and the Leukemia Disease Group Leader at BIDMC. She is currently a member of the Yale Leukemia Clinical and Research Team. Dr. Mendez is dedicated to both the clinical care of patients and translational research to identify novel therapeutics in high-risk myeloid neoplasms/leukemia to improve clinical outcomes for patients. As part of a new precision medicine clinic, she sees patients with precursor conditions (CHIP/CCUS) with the goal of early identification of individuals at high risk for developing myeloid neoplasms/leukemia.